UBS Group’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.6M Buy
916,977
+84,189
+10% +$975K ﹤0.01% 2377
2025
Q1
$7.27M Buy
832,788
+569,261
+216% +$4.97M ﹤0.01% 2651
2024
Q4
$3.78M Buy
263,527
+18,773
+8% +$270K ﹤0.01% 3223
2024
Q3
$5.53M Buy
244,754
+93,197
+61% +$2.1M ﹤0.01% 2193
2024
Q2
$2.95M Buy
151,557
+97,290
+179% +$1.89M ﹤0.01% 2524
2024
Q1
$2.04M Buy
54,267
+48,038
+771% +$1.8M ﹤0.01% 2973
2023
Q4
$349K Sell
6,229
-4,882
-44% -$273K ﹤0.01% 4234
2023
Q3
$458K Buy
11,111
+1,228
+12% +$50.7K ﹤0.01% 3670
2023
Q2
$552K Sell
9,883
-12,589
-56% -$703K ﹤0.01% 3745
2023
Q1
$1.25M Buy
22,472
+17,575
+359% +$981K ﹤0.01% 2995
2022
Q4
$178K Buy
4,897
+3,029
+162% +$110K ﹤0.01% 4460
2022
Q3
$53K Sell
1,868
-1,065
-36% -$30.2K ﹤0.01% 5241
2022
Q2
$132K Sell
2,933
-21,008
-88% -$945K ﹤0.01% 4231
2022
Q1
$1.82M Sell
23,941
-7,150
-23% -$544K ﹤0.01% 2732
2021
Q4
$4.63M Buy
31,091
+2,049
+7% +$305K ﹤0.01% 2165
2021
Q3
$4.23M Buy
29,042
+4,245
+17% +$618K ﹤0.01% 2159
2021
Q2
$4.86M Sell
24,797
-5,530
-18% -$1.08M ﹤0.01% 2042
2021
Q1
$5.49M Sell
30,327
-6,145
-17% -$1.11M ﹤0.01% 1872
2020
Q4
$5.17M Sell
36,472
-27,980
-43% -$3.96M ﹤0.01% 1819
2020
Q3
$8.04M Buy
64,452
+30,471
+90% +$3.8M ﹤0.01% 1408
2020
Q2
$3.04M Buy
33,981
+5,622
+20% +$502K ﹤0.01% 1962
2020
Q1
$1.77M Buy
28,359
+4,160
+17% +$259K ﹤0.01% 2251
2019
Q4
$1.84M Buy
24,199
+23,162
+2,234% +$1.76M ﹤0.01% 2839
2019
Q3
$52K Buy
+1,037
New +$52K ﹤0.01% 5239